Search results
Recent Insider Activity Suggests Potential Gains for Moderna Inc
Knox Daily· 2 days agoHSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target...86 from $75. A number ...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 3 days agoFree Report) is expected to reveal quarterly loss of $3.59 per share, indicating a decline of 1989.5% compared to the year-ago period. Over the past 30 days, the consensus EPS estimate for the ...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO...
Simply Wall St. via Yahoo Finance· 2 days agoLooking ahead, you might want to check this free visual report on analyst forecasts for the...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 2 days agoPfizer PFE is scheduled to release its first-quarter earnings report before the opening bell on May...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 13 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 6 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
Leerink Partnrs Weighs in on Cartesian Therapeutics, Inc.’s Q1 2024 Earnings (NASDAQ:RNAC)
ETF DAILY NEWS· 6 days ago(NASDAQ:RNAC – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2024 earnings estimates for Cartesian Therapeutics in a report released on Tuesday, April 23rd. Leerink Partnrs ...
The most jam-packed earnings week for the quarter lies ahead
Market Watch· 4 days ago, analysts are zeroed in on weaker demand in China, the iPhone upgrade cycle, Vision Pro demand and...